Search Results

Research, 2014) and GPCRs (Feigin, et al., PNAS, 2014) in breast cancer pathogenesis, using mouse models They also discussed his research on cell polarity and its role in cancer progression, his work on G-protein Mike's Research on Cell Polarity and GPCRs in Cancer Mike shared his research on cell polarity and its GPCR Targeted Drugs and Gene Regulation in Cancer Cells Mike presented research on the effect of GPCR-targeted GPCRs and Cancer Immune Modulation Yamina and Mike had a discussion about their research on GPCRs, specifically

Guenter Blobel , before starting my Ph.D. in 2009 at The Scripps Research Institute in La Jolla. Bryan Roth where I established GPCR structural biology and learned the ins and outs of molecular pharmacology How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

S0092-8674(25)00398-8 #DrGPCR #GPCR #Chemokines #StructuralBiology #Pharmacology #ProteinEngineering #Immunology

He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class GPCR Member ResearchGate Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

and Surgeons, New York, New York, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute Niels Bohr Institute, Faculty of Natural Sciences, University of Copenhagen, Copenhagen, Denmark" About New York State Psychiatric Institute, Research Foundation for Mental Hygiene, New York, USA. Neuroscience Institute, Institute for Biophysical Dynamics, and Center for Mechanical Excitability, The Sun as a postdoc/research associate/assistant professor.

After obtaining his Ph.D. in 1994, Randy moved to the Vollum Institute in Portland, Oregon, to do a post-doctoral Randy has received a number of research prizes, including the PhRMA New Investigator Award, the Distinguished Young Scholar in Medical Research Award from the W.M. Randy Hall on the web Hall Lab LinkedIn Google Scholar ResearchGate Dr. Lefkowitz Memoir. Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

began as a focused exploration into Family B GPCRs evolved into a comprehensive resource for the GPCR research autoantibodies activate GPCRs , potentially driving pathophysiology — a paradigm-shifting concept in GPCR immunology Sakmar reflects on the generational shift in research culture. Keyword Cloud GPCR-RAMP interactions , multiplex assays , GPCR research community , Dr. Ilana’s research is multi-disciplinary and involves a close collaboration with the lab of proteomics

In 2021, I joined the Ferring Research Institute of Ferring Pharmaceuticals in San Diego as a scientist Nariman Balenga on the web Researchgate Linkedin.com Google Scholar Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Discover the evolution of GPCR research — from single pipettes to automated platforms shaping precision Home → Flash News → From Pipettes to Platforms The Evolution of GPCR Research From Pipettes to Platforms : The Evolution of GPCR Research Published on November 13, 2025 Category Dr. the episode: https://www.ecosystem.drgpcr.com/post/from-pipettes-to-platforms-the-evolution-of-gpcr-research

He completed postdoctoral training at the Weizmann Institute. In 1983, he joined the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, in Bethesda, MD. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Elva Zhao About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical Her current research focuses on class B GPCRs and understanding how GPCR signaling and function is mediated How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

One insight, one connection, one ‘aha’ moment — can save months of research time. Valid until canceled Join Premium Today! Subject to verification Eligibility Criteria ✔ Live and work in a developing country. ✔ Be employed by an institution opportunities, and tools to accelerate GPCR-related research and career growth. Ready to Advance Your GPCR Research?

Marie1, Bigl, Marina1, America, Michelle2, Vanhollebeke Benoit2, Langenhan Tobias1 1Rudolf Schönheimer Institute , Germany 2Laboratory of Neurovascular Signaling, Department of Molecular Biology, ULB Neuroscience Institute Neil Shneider’s group as a postdoctoral research scientist at Columbia University, New York, where I Department of Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany 2 Rudolf Schönheimer Institute His research focuses on the relevance of aGPCRs in physiology and signaling using both in vitro and in

He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry Peter Gmeiner has been spokesman of the Research Training Group "Medicinal Chemistry of Selective GPCR

He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging supervision of Michel Bouvier at Université de Montréal, followed by a Postdoctoral Fellow at Scripps Research How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

GPCR researchers in Australia and the initiation of a successful series of conferences. Additionally, they explored the unique culture and structure of their Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic commercialization. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, , highlighting the unique opportunities presented by their location and partnerships with other institutions

GPCR researchers in Australia and the initiation of a successful series of conferences. Additionally, they explored the unique culture and structure of their Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic commercialization. Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, , highlighting the unique opportunities presented by their location and partnerships with other institutions

Trejo’s research program is to gain a thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer Trejo’s research has focused on PAR1, which has important functions in hemostasis, thrombosis, inflammation , and cancer and is an important drug target. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

He is the Research director at INSERM with a specific interest in G protein-coupled receptors by developing His laboratory is currently located at the Institute Cochin – Inserm (Paris, France). He was the director of the French network of GPCRs (GDR-3545), currently directs the International Research He is a highly cited researcher – 2019 and 2020 identified by Clarivate Web of Science ™. Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

In 2018 I got married and moved to France, to join the Interdisciplinary Institute for Neurosciences Silvia Sposini on the web Bordeaux Neurocampus LinkedIn ResearchGate X (Twitter) Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

With over 2000 followers on Facebook and Twitter, he shares the latest available information on GPCR research Terry Hébert on the web Institute of Health Sciences Education Hébert Lab LinkedIn Facebook GPCR Consortium How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Discover how GPR65 reshapes our understanding of GPCR signaling and its role in cancer, with Dr. unique academic journey—from early interests in medicine to his pivot toward pharmacology and GPCR research His research centers on the beta-2 adrenergic receptor and GPR65 , a proton-sensing receptor with promising implications in cancer biology. Yamina underscores the therapeutic potential of GPR65, especially in the context of cancer immunotherapy

His doctoral research focused on the structural and functional characterization of bitter taste receptors Jurgen Wess’s lab at the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) - NIH, Sai Prasad Pydi on the web Molecular Metabolism & Cell Signaling Laboratory Website Twitter.com Research How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Join the Adhesion GPCR Workshop 2024 in Mexico City at CINVESTAV, bringing together researchers to explore venue, CINVESTAV - Centro de Investigación y de Estudios Avanzados del IPN (in English: Center for Research and Advanced Studies of the National Polytechnic Institute). Instituto Politécnico Nacional no 2508 Mexico City, C.P. 07360 Room: Auditorium Arturo Rosenblueth *Have Dr.GPCR Newsletter Learn more about the Adhesion GPCR workshop 2024 Up Abstract Submission Submit your research

After spending two years at the Cleveland Institute of Art, he earned degrees in Biochemistry and Chemistry virtual screener, and Python, medical, and graduate educator leading a talented and multidisciplinary research How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research